[go: up one dir, main page]

DK1030667T3 - Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö - Google Patents

Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö

Info

Publication number
DK1030667T3
DK1030667T3 DK98962348T DK98962348T DK1030667T3 DK 1030667 T3 DK1030667 T3 DK 1030667T3 DK 98962348 T DK98962348 T DK 98962348T DK 98962348 T DK98962348 T DK 98962348T DK 1030667 T3 DK1030667 T3 DK 1030667T3
Authority
DK
Denmark
Prior art keywords
mirtazapine
medicament
manufacture
treatment
sleep apnea
Prior art date
Application number
DK98962348T
Other languages
English (en)
Inventor
John Stuart Andrews
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1030667T3 publication Critical patent/DK1030667T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98962348T 1997-11-14 1998-11-13 Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö DK1030667T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97203548 1997-11-14
EP98962348A EP1030667B1 (en) 1997-11-14 1998-11-13 Use of mirtazapine for the manufacture of a medicament for treating sleep apneas
PCT/EP1998/007330 WO1999025356A1 (en) 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas

Publications (1)

Publication Number Publication Date
DK1030667T3 true DK1030667T3 (da) 2005-06-20

Family

ID=8228923

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98962348T DK1030667T3 (da) 1997-11-14 1998-11-13 Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö

Country Status (21)

Country Link
US (1) US6303595B1 (da)
EP (1) EP1030667B1 (da)
JP (1) JP2001522891A (da)
KR (1) KR20010032009A (da)
CN (1) CN1154495C (da)
AT (1) ATE289816T1 (da)
AU (1) AU737590B2 (da)
BR (1) BR9815098A (da)
CA (1) CA2309744A1 (da)
CZ (1) CZ296282B6 (da)
DE (1) DE69829202T2 (da)
DK (1) DK1030667T3 (da)
ES (1) ES2238781T3 (da)
HK (1) HK1029932A1 (da)
HU (1) HUP0100080A3 (da)
IL (2) IL135825A0 (da)
NO (1) NO20002218L (da)
PL (1) PL192272B1 (da)
PT (1) PT1030667E (da)
TR (1) TR200001293T2 (da)
WO (1) WO1999025356A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
DK1066036T3 (da) 1998-02-27 2006-08-21 Univ Illinois Midler med serotoninrelateret aktivitet til behandling af sövnapnö
DE60117122T2 (de) * 2000-02-11 2006-07-27 Akzo Nobel N.V. Verwendung von mirtazapin zur behandlung von schlafstörungen
US20020183306A1 (en) * 2001-05-30 2002-12-05 Pfizer Inc. Combination treatment for sleep disorders including sleep apnea
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
ES2426915T3 (es) 2003-09-10 2013-10-25 Brentwood Equities Ltd. Diastereoisómeros de 4-ariloxi-3-hidroxipiperidinas
WO2006023702A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders with setiptiline
EP1827450A4 (en) * 2004-11-17 2009-04-22 Cypress Bioscience Inc METHOD FOR REDUCING THE SIDE EFFECTS OF TREATMENT WITH MIRTAZAPINE
CA2590802A1 (en) 2004-12-20 2006-06-29 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
JP5635905B2 (ja) 2007-04-11 2014-12-03 メルク・シャープ・エンド・ドーム・ベー・フェー ミルタザピンの調製方法
EP2167096A4 (en) * 2007-06-13 2010-07-14 Cypress Bioscience Inc IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM
EP2861244B1 (en) 2012-06-14 2018-09-19 The Regents Of The University Of Michigan Sleep apnea treatment
PT3261645T (pt) 2015-02-27 2021-06-17 Dechra Ltd Estimulação do apetite, gestão da perda de peso, e tratamento da anorexia em cães e gatos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
WO1997015309A1 (en) * 1995-10-24 1997-05-01 Gruenenthal, Gmbh Method of inhibiting sleep apnea
SE9504537D0 (sv) 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent

Also Published As

Publication number Publication date
AU737590B2 (en) 2001-08-23
KR20010032009A (ko) 2001-04-16
HUP0100080A2 (hu) 2001-08-28
IL135825A (en) 2006-12-31
CA2309744A1 (en) 1999-05-27
EP1030667B1 (en) 2005-03-02
CN1278731A (zh) 2001-01-03
BR9815098A (pt) 2000-10-10
DE69829202D1 (de) 2005-04-07
CZ296282B6 (cs) 2006-02-15
ES2238781T3 (es) 2005-09-01
ATE289816T1 (de) 2005-03-15
CZ20001751A3 (cs) 2000-10-11
WO1999025356A1 (en) 1999-05-27
PL340467A1 (en) 2001-02-12
JP2001522891A (ja) 2001-11-20
PL192272B1 (pl) 2006-09-29
PT1030667E (pt) 2005-06-30
CN1154495C (zh) 2004-06-23
DE69829202T2 (de) 2005-07-21
NO20002218D0 (no) 2000-04-28
HUP0100080A3 (en) 2002-05-28
TR200001293T2 (tr) 2002-09-23
EP1030667A1 (en) 2000-08-30
AU1754899A (en) 1999-06-07
HK1029932A1 (en) 2001-04-20
US6303595B1 (en) 2001-10-16
IL135825A0 (en) 2001-05-20
NO20002218L (no) 2000-05-12

Similar Documents

Publication Publication Date Title
CY1118651T1 (el) Αζακυκλικες ενωσεις για χρηση στην θεραπευτικη αντιμετωπιση ασθενειων που σχετιζονται με τη σεροτονινη
DK1030667T3 (da) Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
CY1110407T1 (el) Συνθεση για χορηγηση σιδηρου για την θεραπεια του συνδρομου σπασμωδικου σκελους
EA200501095A1 (ru) Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
SE0301882D0 (sv) New use I
SE0301886D0 (sv) New use V
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
NO20032027L (no) Effektive antitumorbehandlinger
SE0104248D0 (sv) Method of treatment
SE9802208D0 (sv) Novel compounds
DK1294379T3 (da) En hidtil ukendt anvendelse af deferipron
EE200200337A (et) Uued ühendid ning nende kasutamine
SE9902267D0 (sv) New compounds
SE0004101D0 (sv) New use
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
UY26085A1 (es) N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
SE9802209D0 (sv) Novel compounds
SE9800139D0 (sv) New use
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
EA200601853A1 (ru) Лечение нарушенной дыхательной функции
DK0900085T3 (da) Behandling af overdreven aggression med olanzapin